Founded in 1989 by John Oxford, a leading influenza expert and professor at Queen Mary, the company has grown to become the world leader in providing human challenge studies to test infectious and respiratory products.

Globally, hVIVO are transforming healthcare by revolutionising the drug development process through scientific ingenuity. Locally, in 2011 hVIVO opened their laboratory, screening and 24-bedroom quarantine facilities to Queen Mary BioEnterprises in Whitechapel.

In 2021, they expanded their quarantine facilities (the Whitechapel Clinic) offering volunteers a state-of-the-art clinical trial experience. Since then, hVIVO have continued to invest in East London, with corporate offices on Plumbers Row and bigger laboratories.